Volume 99, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Human strongyloidiasis is widely prevalent in tropical and subtropical regions worldwide but is not endemic in Hawaii. Subclinical, chronic infections may be lifelong; immunosuppressive therapy, particularly with glucocorticoids, may lead to serious or fatal disseminated disease, which is preventable. We performed a retrospective analysis of patients tested for immunoglobulin G antibody in an academic medical center in Honolulu, Hawaii, from 2005 to 2012. Of the 475 patients tested, 78 (16%) were seropositive. The largest proportion of seropositive cases was found among Micronesians (30%), Polynesians (26%), Filipinos (13%), and Southeast Asians (11%). Among the seropositive patients, the most likely reason for clinicians to order testing was blood eosinophilia. Stool parasite examination results were available for 58% of seropositive patients of which 11% were positive for larvae. Antihelminthic therapy, usually ivermectin, was ordered for 71% of patients. After treatment, blood eosinophilia and serology results were reassessed for 76% and 35% of patients, respectively; both tests tended to show improvement. Travelers and immigrants from -endemic areas, including Micronesia and Polynesia, should have serodiagnostic testing for latent strongyloidiasis, and if positive, treated empirically with ivermectin, particularly when corticosteroids or other immunosuppressive therapies are anticipated.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Olsen A, van Lieshout L, Marti H, Polderman T, Polman K, Steinmann P, Stothard R, Thybo S, Verweij JJ, Magnussen P, , 2009. Strongyloidiasis—the most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg 103: 967972. [Google Scholar]
  2. Lam CS, Tong MK, Chan KM, Siu YP, , 2006. Disseminated strongyloidiasis: a retrospective study of clinical course and outcome. Eur J Clin Microbiol Infect Dis 25: 1418. [Google Scholar]
  3. Caruana SR, Kelly HA, Ngeow JY, Ryan NJ, Bennett CM, Chea L, Nuon S, Bak N, Skull SA, Biggs BA, , 2006. Undiagnosed and potentially lethal parasite infections among immigrants and refugees in Australia. J Travel Med 13: 233239. [Google Scholar]
  4. de Silva S, Saykao P, Kelly H, MacIntyre CR, Ryan N, Leydon J, Biggs BA, , 2002. Chronic Strongyloides stercoralis infection in Laotian immigrants and refugees 7–20 years after resettlement in Australia. Epidemiol Infect 128: 439444. [Google Scholar]
  5. Gyorkos TW, Genta RM, Viens P, MacLean JD, , 1990. Seroepidemiology of Strongyloides infection in the southeast Asian refugee population in Canada. Am J Epidemiol 132: 257264. [Google Scholar]
  6. Loutfy MR, Wilson M, Keystone JS, Kain KC, , 2002. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 66: 749752. [Google Scholar]
  7. Igual-Adell R, Oltra-Alcaraz C, Soler-Company E, Sanchez-Sanchez P, Matogo-Oyana J, Rodriguez-Calabuig D, , 2004. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. Expert Opin Pharmacother 5: 26152619. [Google Scholar]
  8. Muennig P, Pallin D, Sell RL, Chan MS, , 1999. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med 340: 773779. [Google Scholar]
  9. Muennig P, Pallin D, Challah C, Khan K, , 2004. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States. Epidemiol Infect 132: 10551063. [Google Scholar]
  10. Centers for Disease Control, 2016. Strongyloidiasis: Resources for Health Professionals. Available at: https://www.cdc.gov/parasites/strongyloides/health_professionals/. Accessed February 2, 2018.
  11. Boulware DR, Stauffer WM, Hendel-Paterson BR, Rocha JL, Seet RC, Summer AP, Nield LS, Supparatpinyo K, Chaiwarith R, Walker PF, , 2007. Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. Am J Med 120: 545.e1-8. [Google Scholar]
  12. Yoshimoto CM, , 1993. Strongyloides infection in Hawaii: an imported case. Hawaii Med J 52: 5961, 76. [Google Scholar]
  13. Schar F, Giardina F, Khieu V, Muth S, Vounatsou P, Marti H, Odermatt P, , 2016. Occurrence of and risk factors for Strongyloides stercoralis infection in south-east Asia. Acta Trop 159: 227238. [Google Scholar]
  14. Tanaka T, Hirata T, Parrott G, Higashiarakawa M, Kinjo T, Kinjo T, Hokama A, Fujita J, , 2016. Relationship among Strongyloides stercoralis infection, human T-cell lymphotropic virus type 1 infection, and cancer: a 24-year cohort inpatient study in Okinawa, Japan. Am J Trop Med Hyg 94: 365370. [Google Scholar]
  15. Posey DL, Blackburn BG, Weinberg M, Flagg EW, Ortega L, Wilson M, Secor WE, Sanders-Lewis K, Won K, Maguire JH, , 2007. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. Nephrol Dial Transplant 45: 13101315. [Google Scholar]
  16. Nuesch R, Zimmerli L, Stockli R, Gyr N, Christoph Hatz FR, , 2005. Imported strongyloidosis: a longitudinal analysis of 31 cases. J Travel Med 12: 8084. [Google Scholar]
  17. Gill GV, Welch E, Bailey JW, Bell DR, Beeching NJ, , 2004. Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. QJM 97: 789795. [Google Scholar]
  18. Suzuki T, Nara N, Miyake S, Eishi Y, Sugiyama E, Aoki N, , 1989. Fatal strongyloidiasis latent over 42 years in the antineoplastic chemotherapy of a case with malignant lymphoma. Jpn J Med 28: 9699. [Google Scholar]
  19. Bisoffi Z, 2014. Diagnostic accuracy of five serologic tests for Strongyloides stercoralis infection. PLoS Negl Trop Dis 8: e2640. [Google Scholar]
  20. Requena-Mendez A, Chiodini P, Bisoffi Z, Buonfrate D, Gotuzzo E, Munoz J, , 2013. The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. PLoS Negl Trop Dis 7: e2002. [Google Scholar]
  21. Gillespie SH, Bidwell D, Voller A, Robertson BD, Maizels RM, , 1993. Diagnosis of human toxocariasis by antigen capture enzyme linked immunosorbent assay. J Clin Pathol 46: 551554. [Google Scholar]
  22. Nguyen T, Cheong FW, Liew JW, Lau YL, , 2016. Seroprevalence of fascioliasis, toxocariasis, strongyloidiasis and cysticercosis in blood samples diagnosed in Medic Medical Center Laboratory, Ho Chi Minh City, Vietnam in 2012. Parasit Vectors 9: 486. [Google Scholar]
  23. Rothenberg ME, , 1998. Eosinophilia. N Engl J Med 338: 15921600. [Google Scholar]
  24. Berk SL, Verghese A, Alvarez S, Hall K, Smith B, , 1987. Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med 147: 12571261. [Google Scholar]
  25. Azira NM, Abdel Rahman MZ, Zeehaida M, , 2013. Review of patients with Strongyloides stercoralis infestation in a tertiary teaching hospital, Kelantan. Malays J Pathol 35: 7176. [Google Scholar]
  26. Siddiqui AA, Berk SL, , 2001. Diagnosis of Strongyloides stercoralis infection. Nephrol Dial Transplant 33: 10401047. [Google Scholar]
  27. Geltman PL, Cochran J, Hedgecock C, , 2003. Intestinal parasites among African refugees resettled in Massachusetts and the impact of an overseas pre-departure treatment program. Am J Trop Med Hyg 69: 657662. [Google Scholar]
  28. Orjuela-Canon AD, Camargo Mendoza JE, Awad Garcia CE, Vergara Vela EP, , 2018. Tuberculosis diagnosis support analysis for precarious health information systems. Comput Methods Programs Biomed 157: 1117. [Google Scholar]

Data & Media loading...

  • Received : 20 Feb 2018
  • Accepted : 30 Apr 2018
  • Published online : 25 Jun 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error